tiprankstipranks
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market

Nuo Therapeutics (AURX) Cash flow

10 Followers

Nuo Therapeutics Cash Flow

AURX's free cash flow for Q was $-671.41K. For the fiscal year, AURX's free cash flow was decreased by $-4.59M and operating cash flow was $-671.41K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 18
Operating Cash Flow
$ -265.97K$ -3.17M$ 1.41M$ -119.95K$ -9.85K$ -874.39K
Investing Cash Flow
$ -7.24K$ -7.24K$ -59.99K-$ 0.00$ 2.00K
Financing Cash Flow
$ 2.00M$ 2.00M$ 4.46M$ 1.37M$ 0.00$ 815.80K
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 4.07M$ 928.68K$ 1.41M$ 1.41M$ 151.59K$ 636.93K
Income Tax Paid Supplemental Data
----$ 0.00$ 0.00
Interest Paid Supplemental Data
$ 4.00K$ 4.00K$ 2.27K-$ 0.00$ 0.00
Issuance Of Capital Stock
$ 2.00M$ 2.00M$ 4.46M--$ 500.00K
Issuance Of Debt
-----$ 315.80K
Repayment Of Debt
------
Free Cash Flow
$ -267.87K$ -3.18M$ 1.41M$ -119.95K$ -9.85K$ -874.39K
Domestic Sales
------
Foreign Sales
------
Currency in USD

Nuo Therapeutics Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis